TSR-042

Investors ding Tesaro despite responses for combo in NSCLC
BioCentury
Sat, 11/10/18 - 12:44 pm
Tesaro
non-small cell lung cancer
clinical trials
TSR-042
How Tesaro Hopes to Tackle Lung Cancer
Motley Fool
Fri, 09/7/18 - 11:07 am
Tesaro
TSR-042
non-small cell lung cancer